En sådan opdagelse åbner op for muligheden, at man kan "skræddersy" medicin, der påvirker denne ionkanal.
Læs artiklen om opdagelsen:
Loss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome:
"Conclusions: About 2% of patients with IBS carry mutations in SCN5A. Most of these are loss-of-function mutations that disrupt NaV1.5 channel function. These findings provide a new pathogenic mechanism for IBS and possible treatment options."
Ingen kommentarer:
Send en kommentar
Bemærk! Kun medlemmer af denne blog kan sende kommentarer.